CELLCENTRIC LTD
Patent Applications and Registrations
Patent applications and USPTO patent grants for CELLCENTRIC LTD.The latest application filed is for "process for preparing modulators of p300 and/or cbp".
- CELLCENTRIC LTD - Cambridge N/A GB
- CELLCENTRIC LIMITED - Cambridge GB
- CELLCENTRIC LTD - Cambridge Cambridgeshire GB
- CellCentric Limited - GB GB
- CELLCENTRIC LIMITED; - Essex GB
- CellCentric Limited - Essex GB
| Patent | Date |
|---|---|
| Process for preparing modulators of p300 and/or CBP Grant 11,453,662 - Baguley , et al. September 27, 2 | 2022-09-27 |
| Pharmaceutical compounds Grant 11,377,443 - Pegg , et al. July 5, 2 | 2022-07-05 |
| Process For Preparing Modulators Of P300 And/or Cbp App 20210163463 - BAGULEY; Paul ; et al. | 2021-06-03 |
| Pharmaceutical Compounds App 20200407349 - PEGG; Neil Anthony ; et al. | 2020-12-31 |
| Pharmaceutical compounds Grant 10,696,666 - Pegg , et al. June 30, 2 | 2020-06-30 |
| Pharmaceutical compounds Grant 10,647,704 - Pegg , et al. | 2020-05-12 |
| Pharmaceutical Compounds App 20190375740 - PEGG; Neil Anthony ; et al. | 2019-12-12 |
| Isoxazolyl substituted imidazopyridines Grant 10,428,065 - Pegg , et al. October 1, 2 | 2019-10-01 |
| Pharmaceutical Compounds App 20190263788 - PEGG; Neil Anthony ; et al. | 2019-08-29 |
| Isoxazolyl substituted benzimidazoles Grant 10,118,920 - Pegg , et al. November 6, 2 | 2018-11-06 |
| Isoxazolyl Substituted Benzimidazoles App 20180127402 - PEGG; Neil Anthony ; et al. | 2018-05-10 |
| Isoxazolyl Substituted Imidazopyridines App 20180105519 - PEGG; Neil Anthony ; et al. | 2018-04-19 |
| Molecules and methods for demethylation of methylated nucleic acid sequences Grant 8,658,393 - Reik , et al. February 25, 2 | 2014-02-25 |
| Molecules And Methods For Demethylation Of Methylated Nucleic Acid Sequences App 20130034881 - Reik; Wolf ; et al. | 2013-02-07 |
| Compositions and method for epigenetic modification of nucleic acid sequences in vivo Grant 8,298,529 - Reik , et al. October 30, 2 | 2012-10-30 |
| Compositions and Method for Epigenetic Modification of Nucleic Acid Sequences in Vivo App 20110138491 - Reik; Wolf ; et al. | 2011-06-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 